You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Overcoming Tramadol Resistance In CYP2D6 Poor Metabolizers

    SBC: Syntrix Biosystems, Inc.            Topic: NIDA

    DESCRIPTION (provided by applicant): Tramadol is a widely prescribed analgesic, with over 25 million prescriptions and 565 million in retail sales in 2009, making it among the best selling generic drugs. One of the advantages of tramadol over traditionalopioids is its lower risk of opioid dependence, resulting in it having an unscheduled status in the U.S. and other countries. Although its mode ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  2. Piezoelectric Pipetting for High Density Nucleic Acid Programmable Protein Arrays

    SBC: ENGINEERING ARTS, LLC            Topic: NIGMS

    DESCRIPTION (provided by applicant): Among the currently available techniques for high throughput proteomics, protein microarrays have the greatest prospects to revolutionize molecular diagnostics for early detection, diagnosis, treatment, prognosis and monitoring clinical response. However, protein microarrays have yet to reach their full potential as a research or clinical molecular diagnostics ...

    STTR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  3. Antifibrotic Therapy for Chronic Kidney Disease

    SBC: Angion Biomedica Corp.            Topic: NIDDK

    DESCRIPTION (provided by applicant): Chronic kidney disease (CKD) remains an unsolved challenge for the nephrologist, as it almost inevitably leads to end-stage renal failure, a life-threatening condition that necessitates renal replacement therapy. Few, if any, of the currently practiced therapeutic strategies oppose the molecular and cellular program of fibrosis that drives renal disease. There ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  4. Prospective/Retrospective Motion Correction System for Motion Robust Pediatric MR

    SBC: ROBIN MEDICAL INC            Topic: NIMH

    DESCRIPTION (provided by applicant): The long term objective of the project is to develop a new motion robust magnetic resonance imaging (MRI) technology. Magnetic resonance imaging is a powerful tool that aids in the diagnosis of individual subjects, guides their clinical care, ad provides insights into the mechanisms of normal and atypical development. The characterization of mental health disor ...

    STTR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  5. Device to Improve Treatment of Colorectal CA using O2 Dependent Phosphorescence

    SBC: SURGISENSE CORPORATION            Topic: NCI

    DESCRIPTION (provided by applicant): Standard of care for surgical resection of rectal cancer is the performance of low anterior resection (LAR). After removal of the cancerous segment, a surgical stapler is used to restore continuity by creating an anastomosis between the resulting ends of disjointed bowel. Anastomotic leak is one of the most dreaded complications of colorectal surgery due to the ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  6. Melanocortin Ligands in Disease Cachexia

    SBC: TENSIVE CONTROLS, INC.            Topic: NCI

    DESCRIPTION (provided by applicant): Cachexia-anorexia syndrome is a life-threatening aspect to many diseases, in particular many forms of cancer or therapies for cancer. The obvious symptoms of this disease include lack of appetite, and a loss of lean body mass disproportionate to the reduction in caloric intake. However, the less obvious effects include multi-organ failure, due to high metabolic ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  7. Therapeutic peanut allergen Fc gamma chimeric proteins to treat peanut allergy

    SBC: TUNITAS THERAPEUTICS, INC.            Topic: NIAID

    DESCRIPTION (provided by applicant): The overall goal of this Phase 2 STTR is to develop and commercialize a novel approach for allergen specific immunotherapy as a treatment for severe food allergy. Currently treatment to prevent severe food reactions isa major unmet need. There is no effective therapy, the only treatment being strict avoidance and emergency measures should an exposure occur. Th ...

    STTR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  8. Development of a Miniature Hydrodynamically Suspended Intrathoracic Tesla Pump

    SBC: Minnetronix Medical, Inc.            Topic: NHLBI

    DESCRIPTION (provided by applicant): The long term objective of this research is to commercialize a completely implantable LVAD system that is less expensive, more reliable and more biocompatible than existing percutaneous LVAD systems. Left ventricular assist devices (LVADs) have significantly improved survival in patients bridged to transplant and in destination therapy for end stage heart failu ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  9. Noninvasive Assessment of Neuromuscular Disease using Electrical Impedance

    SBC: MYOLEX, INC.            Topic: NINDS

    DESCRIPTION (provided by applicant): The neuromuscular disorders include a wide group of conditions ranging from relatively mild focal problems, such as carpal tunnel syndrome, to severe, generalized diseases, such as amyotrophic lateral sclerosis (ALS). Current methods for evaluating these disorders remain limited to a variety of tests and procedures that are either invasive or remarkably qualita ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  10. Soluble high-affinity T cell receptors prevent MRSA lethality

    SBC: IMMUVEN, INC.            Topic: NIAID

    DESCRIPTION (provided by applicant): Methicillin resistant Staphylococcus aureus (MRSA) and methicillin sensitive S. aureus (MSSA) are highly significant human health threats that are responsible for a range of diseases. Recently, the CDC and colleagues reported that MRSA are the most significant causes of serious infections and infectious disease deaths in the United States. A major factor involv ...

    SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government